Viewpoints: How iRhythm Technologies is Patching into the Future of Arrhythmia Detection

iRhythm's Zio ECG monitors use FDA-cleared deep-learned AI, clinically proven as accurate as cardiologists, detecting 13 arrhythmia types plus sinus rhythm over up to 14 days.

At HRS 2026, studies showed 30% of post-ablation AF recurrences and 60% of pregnancy arrhythmias detected beyond 48 hours, missed by short-term Holter monitoring.

In pregnant patients, 37.7% had arrhythmias (13.6% clinically significant), mostly after 48 hours, highlighting need for extended monitoring.

Zio provides 99% physician agreement and comprehensive full-wear analysis, transforming arrhythmia diagnosis with AI and wearable tech.

Sources: